Finance

Lists
HURA:NASDAQ
TuHURA Biosciences Inc
US$ १.६६
+१.८४%
(+०.०३०) 1D
US$ १.६४
-१.२०% (-०.०२०)
After hours
Closed: नोभेम्बर ९, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HURA...
Open
US$ १.७०
High
US$ १.७५
Low
US$ १.६५
Mkt. cap
१०.५८ करोड
Avg. vol.
३.८१ लाख
Volume
४.०१ लाख
52-wk high
US$ ३.४१
52-wk low
US$ ०.४१
EPS
-US$ ०.५४
Beta
-०.२३
Shares outstanding
६.३७ करोड
No. of employees
२२
Open
US$ १.७०
High
US$ १.७५
Low
US$ १.६५
Mkt. cap
१०.५८ करोड
Avg. vol.
३.८१ लाख
Volume
४.०१ लाख
52-wk high
US$ ३.४१
52-wk low
US$ ०.४१
EPS
-US$ ०.५४
Beta
-०.२३
Shares outstanding
६.३७ करोड
No. of employees
२२
News stories
From web sources and news partners
Quantisnow
Quantisnow
·
१ मिनेट पहिले
Occidental Announces Third Quarter 2026 Results
shattered.io
shattered.io
·
१ घण्टा पहिले
Stacey Cunningham: 1st Woman NYSE Chief Bullish [2026]
Yahoo Finance
Yahoo Finance
·
१९ मिनेट पहिले
IRulya Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Bloomberg.com
Bloomberg.com
·
२१ घण्टा पहिले
Watch 95% S&P 500, 5% Bitcoin in New Franklin ETF: Drilldown
About TuHURA Biosciences Inc
CEO-
Employees२२
Founded१९९५
Headquartersताम्पा, फ्लोरिडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitetuhurabio.com
Analyst ratings
Based on 2 analysts giving stock ratings to HURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HURA in the last 3 months.
Highest
Current US$ १.६६
US$ १०.०० (+५०२.४१%)
Average
US$ ९.०० (+४४२.१७%)
Lowest
US$ ८.०० (+३८१.९३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ १०.००
+५०२.४%
10/27/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ८.००
+३८१.९%
08/25/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
US$ ९.००
+४४२.२%
04/27/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
US$ ९.००
+४४२.२%
04/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$ ७.००
+३२१.७%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४९.६९ लाख
६०.५५ लाख
५२.३३ लाख
६६.२० लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१७.६१ लाख
२३.३८ लाख
२२.९७ लाख
२१.४३ लाख
Operating expense
६७.३० लाख
८३.९४ लाख
७५.३० लाख
८७.६३ लाख
Total operating expenses
६७.३० लाख
८३.९४ लाख
७५.३० लाख
८७.६३ लाख
Operating income
-६७.३० लाख
-८३.९४ लाख
-७५.३० लाख
-८७.६३ लाख
Other non operating income
-४६.७२ हजार
१.८५ लाख
-
-
EBT including unusual items
-७१.०२ लाख
-६७.६१ लाख
-७५.३७ लाख
-९२.२३ लाख
EBT excluding unusual items
-६७.८७ लाख
-८८.१७ लाख
-७५.३७ लाख
-९२.२३ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-७१.०२ लाख
-६७.६१ लाख
-७५.३७ लाख
-९२.२३ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.१४
-०.१६
-०.१३
-
Interest and investment income
६.०६ हजार
६०९.००
२१.२८ हजार
७.६२ हजार
Interest expense
-१६.५३ हजार
-६.०९ लाख
-२७.९७ हजार
-४.६८ लाख
Net interest expenses
-१०.४७ हजार
-६.०८ लाख
-६.७० हजार
-४.६० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-६७.०८ लाख
-८३.७१ लाख
-७५.०६ लाख
-८७.३५ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू